{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:34:57Z","timestamp":1773725697388,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Merck Sharp & Dohme R&D (China) Co., Ltd."}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.08.081","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:46:03Z","timestamp":1505868363000},"page":"5897-5904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"35","author":[{"given":"Zhaojun","family":"Mo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingkai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Botao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanzheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy A.","family":"Hille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micki","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.08.081_b0005","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000\u20132013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.081_b0010","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1016\/j.vaccine.2011.07.104","article-title":"Hospital-based study of the economic burden associated with rotavirus diarrhea in eastern China","volume":"29","author":"Jin","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2017.08.081_b0015","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/INF.0000000000000799","article-title":"Rotavirus-specific and overall diarrhea mortality in Chinese children younger than 5 years: 2003 to 2012","volume":"34","author":"Zhang","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.081_b0020","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1086\/431505","article-title":"Sentinel Hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001\u2013July2003","volume":"192","author":"Fang","year":"2005","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.081_b0025","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1086\/605039","article-title":"Hospital based surveillance of rotavirus diarrhea in the People's Republic of China, August 2003-July 2007","volume":"200","author":"Duan","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.08.081_b0030","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.vaccine.2011.12.092","article-title":"Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systemic review","volume":"30","author":"Kawai","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.081_b0035","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1016\/j.vaccine.2012.05.084","article-title":"Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.081_b0040","doi-asserted-by":"crossref","unstructured":"Soares-Weiser K, MacLehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD008521. http:\/\/dx.doi.org\/10.1002\/14651858.CD008521.pub2.","DOI":"10.1002\/14651858.CD008521.pub2"},{"key":"10.1016\/j.vaccine.2017.08.081_b0045","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1128\/JCM.43.12.5876-5880.2005","article-title":"Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis","volume":"43","author":"DiStefano","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"30 Suppl 1","key":"10.1016\/j.vaccine.2017.08.081_b0050","doi-asserted-by":"crossref","first-page":"A159","DOI":"10.1016\/j.vaccine.2011.07.126","article-title":"Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia","volume":"27","author":"Lewis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.081_b0055","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4161\/hv.24846","article-title":"Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"9","author":"Iwata","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.08.081_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.vaccine.2009.10.041","article-title":"RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe","volume":"28","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.08.081_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/peds.2006-2058","article-title":"Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life","volume":"119","author":"Block","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2017.08.081_b0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.081_b0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.08.081_b0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.08.081_b0085","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/j.vaccine.2011.08.124","article-title":"Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine","volume":"30","author":"Breiman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.081_b0090","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2014.06.018","article-title":"Update on the disease burden and circulating strains of rotavirus in China: a systematic review and meta-analysis","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.08.081_b0095","first-page":"202","article-title":"Prevalence of genotype G9P[8] a rotavirus and acute diarrhea in children, Guangxi, China in 2010","volume":"2","author":"Dong","year":"2012","journal-title":"Chin J Viral Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.08.081_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/INF.0000000000000505","article-title":"Active, population based surveillance for rotavirus gastroenteritis in Chinese children: Beijing Municipality and Gansu Province, China","volume":"34","author":"Zhang","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2017.08.081_b0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in U.S. Infants","volume":"370","author":"Yih","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.08.081_b0110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1542\/peds.2012-2554","article-title":"Intussusception after rotavirus vaccines reported to US VAERS, 2006\u20132012","volume":"131","author":"Haber","year":"2013","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.vaccine.2017.08.081_b0115","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s national immunisation program","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2017.08.081_b0120","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.vaccine.2011.01.088","article-title":"Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia","volume":"29","author":"Buttery","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.081_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e3181af8605","article-title":"Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine","volume":"29","author":"Belongia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.08.081_b0130","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.2012.97","article-title":"Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants","volume":"307","author":"Shui","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2017.08.081_b0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of Intussusception after Monovalent Rotavirus Vaccination","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2017.08.081_b0140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMe1315836","article-title":"Rotavirus vaccines\u2013balancing intussusception risks and health benefits","volume":"370","author":"Glass","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2017.08.081_b0145","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1080\/21645515.2016.1197452","article-title":"Rotavirus vaccination and intussusception \u2013 Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries","volume":"12","author":"Yen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.08.081_b0150","first-page":"49","article-title":"Rotavirus vaccines WHO position paper \u2013 January 2013","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Weekly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2017.08.081_b0155","unstructured":"Centers for Disease Control and Prevention. Rotavirus vaccine information statements. <http:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/rotavirus.html>."},{"issue":"7","key":"10.1016\/j.vaccine.2017.08.081_b0160","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4161\/hv.7.7.15511","article-title":"Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries","volume":"7","author":"Giaquinto","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2017.08.081_b0165","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.vaccine.2009.10.075","article-title":"Reduction in hospitalizations for diarrhea and rotavirus infections in New York state following introduction of rotavirus vaccine","volume":"28","author":"Chang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.08.081_b0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.2008-3528","article-title":"Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine","volume":"124","author":"Tate","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.08.081_b0175","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/cid\/civ872","article-title":"Long-term consistency in rotavirus vaccine protection: RV5 and RV1 vaccine effectiveness in US children, 2012\u20132013","volume":"61","author":"Payne","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17311817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T08:48:22Z","timestamp":1531558102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17311817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17311817"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}